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Abstract Insect bite hypersensitivity (IBH) is a chronic
allergic dermatitis common in horses. Affected horses
mainly react against antigens present in the saliva from
the biting midges, Culicoides ssp, and occasionally black
flies, Simulium ssp. Because of this insect dependency, the
disease is clearly seasonal and prevalence varies between
geographical locations. For two distinct horse breeds, we
genotyped four microsatellite markers positioned within the
MHC class II region and sequenced the highly polymorphic
exons two from DRA and DRB3, respectively. Initially, 94
IBH-affected and 93 unaffected Swedish born Icelandic
horses were tested for genetic association. These horses had
previously been genotyped on the Illumina Equine SNP50
BeadChip, which made it possible to ensure that our study
did not suffer from the effects of stratification. The second
population consisted of 106 unaffected and 80 IBH-affected
Exmoor ponies. We show that variants in the MHC class II
region are associated with disease susceptibility (praw=
2.34×10
−5), with the same allele (COR112:274) associated
in two separate populations. In addition, we combined
microsatellite and sequencing data in order to investigate
the pattern of homozygosity and show that homozygosity
across the entire MHC class II region is associated with a
higher risk of developing IBH (p=0.0013). To our
knowledge this is the first time in any atopic dermatitis
suffering species, including man, where the same risk allele
has been identified in two distinct populations.
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Insect bite hypersensitivity (IBH; also known as “sweet
itch”) is a chronic allergic dermatitis that is common in
horses. A veterinary handbook from the Tang Dynasty in
China contains the first known record of the disease (Li and
Ji 1959). Since then, numerous reports describing the
disease in a wide range of horse breeds and across most
continents have been published (Henry and Bory 1937;
Datta 1939;M c C a i g1973). The association to biting
midges of the Culicoides species was established in the
1950s (Riek 1953; Nakamura et al. 1956; Ishihara 1957).
Horses with IBH mainly react against protein antigens
present in the saliva of biting midges, Culicoides ssp, and
occasionally black flies, Simulium ssp (Mellor and McCraig
1974; Hellberg et al. 2006; Hellberg et al. 2009). Because
of this dependency on insects, the disease is clearly
seasonal and prevalence varies between geographical
locations (Riek 1953; Brostrom et al. 1987).
The acute stage of the disease involves an IgE-mediated
type I hypersensitivity reaction (Wagner et al. 2006).
However, other immunological reactions, such as delayed
type IV hypersensitivity, cannot be excluded during the
chronic stages of the disease (Fadok and Greiner 1990).
Skin sections reveal infiltration of eosinophils and mast
cells as well as increased numbers of IgE-bearing cells, an
increased total number of Tcells and expression of T helper
cells (Th2) (Van der Haegen et al. 2001; Heimann et al.
2011). Clinical signs include intensely pruritic lesions,
urticaria, oedema and papules (Baker and Quinn 1978;
Halldordsottir and Larsen 1991). These are usually most
prominent along the dorsal midline, in particular the tail
base, mane, head, withers and rump. Horses suffering from
IBH that have been left unattended can easily be recognized
by the almost complete loss of hair from the mane and tail
and continuous scratching may cause open wounds.
Secondary symptoms include lichenification, crusts and
scaling.
In Sweden, the Icelandic Horse is one of the breeds most
frequently affected by IBH. In this breed, the prevalence
among horses born in Sweden is approximately 8%, whilst
it is as high as 26–35% for horses born in Iceland and
imported to Sweden (Brostrom et al. 1987; Bjornsdottir et
al. 2006). Culicoides ssp are not known to exist in Iceland,
and the difference in disease prevalence may be due to
native horses not being exposed to bites in early life (Marti
et al. 2008). This conclusion is supported by the fact that
imported horses often experience a more severe form of
IBH than their Swedish-born counterparts (Brostrom et al.
1987).
The present study examines both the Icelandic Horse and
a second breed, the Exmoor Pony. IBH is also a significant
problem in terms of numbers affected and disease severity
in this old, native British pony (personal communications,
Exmoor Pony Society). The Icelandic horses and Exmoor
ponies are clearly two separate populations. This has been
demonstrated in several phylogenetic studies where micro-
satellite markers have been utilized to calculate genetic
distances (Juras et al. 2003; Bömcke et al. 2011).
IBH is partly under genetic control and the heritability in
Icelandic horses has been estimated at 0.3 (Eriksson et al.
2008). Two studies have shown serologically that certain
horse major histocompatibility complexes (MHC), i.e.
equine leukocyte antigen (ELA) class II specificities, are
linked to IBH susceptibility. In an examination of 303
exported Icelandic horses, for 25 different leukocyte
antigens specificities, the allele frequency for Be8 was
significantly different in affected horses versus unaffected
controls (Halldorsdottir et al. 1991). However, the related-
ness of the horses was not described in that study and
potential stratification may have been missed. In another
study, the ELA class II specificity W23 was shown to
segregate with IBH susceptibility in a family-based study
consisting 24 typed Swiss warm-blooded horses (Marti et
al. 1992; Lazary et al. 1994).
In humans, human leukocyte antigen (HLA) class II
plays a role in the pathogenesis of several allergic
phenotypes, for example, pollen, peanut and cow milk
allergies as well as gluten intolerance (Zwollo et al. 1989;
Petronzelli et al. 1997; Camponeschi et al. 1997; Howell et
al. 1998). Certain HLA variants are also associated with an
increased risk of human atopic dermatitis, a disease that
partially resembles equine IBH (Saeki et al. 1995; Kiyohara
et al. 2008).
The ELA class II region is positioned on horse
chromosome 20q and harbours three DQA loci, two DQB
loci and three DRB loci (Tseng et al. 2010). Only one copy
of the DRA locus is present in the horse genome; however,
contrary to many other species, this gene is polymorphic in
the domestic horse, with at least four different alleles
identified (Bailey 1994; Albright-Fraser et al. 1996; Brown
et al. 2004). In the present study, the first to use DNA
genotyping as a substitute for ELA serology, we show that
the ELA class II region in horses is associated with IBH
susceptibility. In addition, we show that the same genetic
risk factors are present in two distinct breeds.
Materials and methods
Animal resources
W ei n i t i a l l yu s e d9 4I B H - a f f e c t e da n d9 3u n a f f e c t e d
Icelandic horses to test for associations between ELA class
II markers and disease status. All horses were born in
Sweden except for one (an unaffected horse exported from
202 Immunogenetics (2012) 64:201–208Iceland) and certified by the Icelandic Horse breed registry.
The horses consisted of paternal half-siblings sired by 42
different stallions. The number of offspring per stallion
ranged from 1 to 24 (median 3, average 4.45). The stallions
were represented by an equal number of affected and
unaffected offspring in order to avoid stratification but were
not themselves included. We were unable to find matching
controls for five horses and so we compensated by adding
unrelated controls. All horses were unrelated on the
maternal side for at least two generations. None of the
controls were from areas with a known low Culicoides ssp
pressure such as coastlines. The average age of affected
horses was 11.5 years (median 11, range 4–21), whilst for
control horses this was 11.0 (median 10, range 4–27).
We also investigated a second population consisting of106
unaffected and 80 IBH-affected Exmoor ponies. These 24
stallions, 51 geldings and 111 mares were all ponies living in
the UK and registered with the Exmoor Pony Society. Family
relationships were not considered in the selection of these
ponies. The average age of the affected ponies was 10.6 years
(median 8, range 1–42) and of the controls was 11.5 years
(median10,range1–37).Thecontrolswerenotselectedbased
on any parameter other than disease status.
The study was approved by the Ethics Committee for
Animal Experiments in Uppsala, Sweden, for the Icelandic
horses and the Animal Health Trust Clinical Research
Ethics Committee in Newmarket, UK, for the Exmoor
ponies. Signed consent was obtained from all horse owners.
Phenotype assessment
Icelandic horses were scored as affected or unaffected
based on a questionnaire sent to owners (Eriksson et al.
2008). Inclusion criteria for an affected horse were defined
as clearly seasonal signs of IBH for a minimum of the two
preceding grazing seasons before the questionnaire was
filled out and returned. Only horses with no history of
pruritic skin problems were selected as unaffected con-
trols. The Exmoor ponies were classed as either affected
or unaffected based on written owner reports of significant
IBH signs at any time during the lifetime of the pony.
Genotyping and sequencing
In a separate study, all Icelandic horses were genotyped
on the Illumina Equine SNP50 BeadChip (unpublished
data). These data were used to assess the population for
stratification. A paucity of SNPs covering the MHC II
region (average distance between SNPs is 76 kb) led us
to more densely cover this area with both microsatellite
markers and direct sequencing of two exons.
Six microsatellite markers were interrogated (COR112,
COR113, UM011, COR114, AHT004 and Autosomal1;
Online resource 1). AHT004 and Autosomal1 were only
used for LD calculations and had nine and two alleles,
respectively. The latter was developed from the horse
reference genome in the same way as described earlier
(Andersson et al. 2008). An M13 tail was added to the
forward primers to facilitate labelling with FAM or VIC.
PCR reactions were carried out as described previously
(Andersson et al. 2008). Amplified fragments were multi-
plexed and separated using a MegaBACE™ 1000 instru-
ment (GE Healthcare, Sweden) according to the
manufacturer’s recommendations, prior to analysis with
Genetic Profiler version 2.2 (GE Healthcare, Sweden).
PCR-amplified exon 2 from each of the MHC class II
genes DRA and DRB3 were sequenced by traditional
Sanger methodology. Primer design and reactions were
carried out as described previously (Andersson et al. 2008).
Results were analysed in CodonCode Aligner version 3.0.1
(CodonCode Corporation, USA). Because of the high
density of SNPs, we could easily designate DRB3 and
DRA alleles manually. All genotypes were carefully
checked for inheritance error, which would indicate the
existence of dropouts (alleles that do not amplify), mistakes
in phasing or non-specific amplification. All sequences
have been deposited to GenBank; accession numbers can
be found in Online resources 2 and 3. The DRA alleles were
named according to previously established nomenclature
(Janova et al. 2009). This was not possible for DRB3 alleles
due to the lack of distinction between different loci and
because the polymorphic 5′ end of exon 2 is missing in
most published sequences. However, a BLAST search
(www.ncbi.nlm.nih.gov) was performed in order to find
similar DRB3 alleles and we refer to the names established
previously (Diaz et al. 2001). A schematic representation of
the genes and markers in horse ELA class II region is
available in Online resource 4.
Data analysis
PLINK (Purcell et al. 2007) was used to examine the SNP
data for genomic inflation factor. For microsatellites, the
average number of alleles and private allelic richness were
calculated in HP-RARE v1.0 (Kalinowski 2005). Pair-wise
linkage disequilibrium (LD)was calculatedusingthe metricx
2′,
a standardized chi-square statistic suitable for use with multi-
allelic markers (Zhao et al. 2005) where, for biallelic markers,
x
2′=r
2. Two-marker haplotype frequency estimations and LD
calculations were performed as reported previously (Meadows
et al. 2008). Non-syntenic LD was estimated from the
Icelandic Horse population using three microsatellite markers
located on chromosome 6, 20 and 24, respectively (Online
resources 1). R (Team 2008) was used for most statistical
calculations. Alleles with frequencies less than 0.10 and
0.075 for microsatellites and exon 2 sequences (DRA and
Immunogenetics (2012) 64:201–208 203DRB3), respectively, were pooled. Each marker was then
analysed in a 2×N contingency table and Fisher exact tests
were used to generate p-values and odds ratios for
differences in allele frequencies in a 2×2 table (one allele
vs. all other). Cochran–Mantel–Haenszel tests for differ-
ences in allele frequencies were performed in the SAS
package (SAS 2010). Bonferroni correction was used to
adjust for multiple testing in the initial scan for associa-
tion; this was over-conservative as the tests were not
independent. FastPHASE was used for phasing combined




Approximately 44,200 SNPs were used to evaluate the
Icelandic horse sample set for potential population stratifi-
cation. The result from an allelic case/control test was
compared to the expected distribution of p-values. The
genomic inflation factor was 1.00 (mean 0.90), which
implies a low risk of false positives due to population
stratification. No genomewide data were available for the
Exmoor ponies.
Genotyping of MHC class II microsatellites
In total, we genotyped four microsatellite markers, posi-
tioned within the MHC class II region, in 185 Icelandic
horses (Table 1) and 186 Exmoor ponies (Table 2). The
average number of alleles (AN) was higher in the Icelandic
horses (AN=9.50) compared to the Exmoor ponies (AN=
7.75). The Icelandic horses also had more private alleles,
measured by private allele richness (pAR=2.25), compared
to the Exmoor ponies (pAR=0.50). For the Icelandic horses,
the degree of LD between markers ranged from 0.31 to 0.59
(Online resource 5). This was considerably higher than the
non-syntenic LD, which was estimated at 0.067.
Since the Icelandic horses did not appear to be stratified,
we first tested these for association between genotypes and
IBH status. Marker COR112 was clearly associated with
IBH status (praw=0.001, pcorr=0.006). Allele 274 was
enriched in cases (f=0.22) compared to controls (f=0.06)
with an odds ratio of 4.19 (95% CI=2.00–9.44, p=2.34×
10
−5). None of the remaining microsatellite markers were
significantly associated with IBH when analysed with the
appropriate degrees of freedom (Table 1). However, when
performing a Fisher exact test, analysing only the allele
with the highest frequency difference between IBH affected
horses and unaffected controls against all other alleles, the
two microsatellite markers closest to COR112 were also
associated, praw=0.037 for COR113 (allele 282) and praw=
0.033 for UM011 (allele 180). This association did not hold





All four MHC class II microsatellites were subsequently
genotyped in the Exmoor ponies (Table 2). In this breed,
COR112 was the only marker in which the same allele
(274) was associated with disease as in the Icelandic Horse.
The frequency of allele 274 in the affected horses was 0.60
compared to 0.50 in healthy ponies (praw=0.043). Further,
UM011 allele 186 was associated with disease when tested
independently in the Exmoor Pony. In Icelandic horses, the
allele frequency of UM011 allele 186 was 0.26 in both
affected horses and controls (data not shown).
Sequencing of DRA and DRB3 genes
The highly polymorphic exon 2 was sequenced in two
genes within the Equine MHC class II region. The DRA
gene was selected because, unlike in many species, it shows
variation in the horse. DRA exists as a single copy, so
sequencing this particular gene reduced the possibility of
Table 1 Association results between ELA markers and IBH in Icelandic horses
IBH Healthy
Marker Position (bp) p-value
(2×N)
df Ad Number, np (Ad) Number, np (Ad) p-values
(2×2)
OR 95% OR
DRA 32690939 0.025 2 DRA*0201 94 0.17 91 0.08 0.012 2.28 1.15–4.71
COR112 33282436 0.001 5 274 86 0.22 87 0.06 2.34×10
−5 4.19 2.00–9.44
DRB3 33364480 0.008 3 1.2 91 0.13 91 0.04 0.004 3.60 1.45–10.2
COR113 33480825 0.271 3 282 89 0.14 86 0.07 0.037 2.17 1.01–4.93
UM011 33510120 0.151 4 180 90 0.13 86 0.06 0.033 2.25 1.02–5.26
COR114 33516304 0.354 4 259 89 0.13 89 0.08 0.229 1.61 0.77–3.45
df degrees of freedom, Ad allele most strongly associated with disease, p( A d) frequency of Ad, OR odds ratios
204 Immunogenetics (2012) 64:201–208paralog gene amplification. The DRB3 gene was selected as
it is one of the most polymorphic genes in the genome and
can be specifically amplified (personal communications).
However, since the DRB gene exists in three copies, the
alleles inherited from each stallion were carefully checked
for Mendelian errors.
In the DRB3 gene, we found 30 SNPs and two indels,
which after phasing constitute eight different alleles
(Table 3; Online resource 2). Our alleles are defined by a
combination of coding and non-coding sequences. One
indel (g.33364687insT) is a thymine insertion positioned
approximately 100 bp upstream of the exon 2 start site. The
other indel (g.33364942delCGGCGGAGCGCCGAG)
resides within the coding region and is a 15-bp deletion.
Since this indel corresponds to exactly five amino acids, the
reading frame of the protein remains intact. Only five of the
eight alleles were found in the Exmoor ponies, with the
most common allele present at a frequency of 0.66. In
summary, 19 SNPs introduced an amino acid change and
produced in total five different polypeptide variants (Online
resource 6). Apart from allele 5, these alleles have been
described previously (Fraser and Bailey 1996). The first
amino acids are lacking in the published DRB sequences;
however, we provide additional novel sequence 5′ of the
coding region, thus extending previously published
sequences. Alleles 1, 1.2 and 2 further distinguish the
allele designated as ELA-DRB*11. It is the very start of
the sequences, not included in published DRB sequences,
which differentiates allele 2 from alleles 1 and 1.2. The
coding sequences of alleles 3, 3.1 and 3.2 are identical and
correspond to ELA-DRB*6, while allele 4 corresponds to
ELA-DRB*9.
Table 2 Association results between ELA markers and IBH in Exmoor ponies
IBH Healthy
Marker Position (bp) p-value
(2×N)
df Ad Number, np (Ad) Number, np (Ad) p-values
(2×2)
OR 95% OR
DRA 32690939 0.332 1 DRA*0201 79 0.23 99 0.28 0.332 0.78 0.46–1.29
COR112 33282436 0.111 2 274 77 0.60 99 0.50 0.043
a 1.48 0.97–2.27
DRB3 33364480 0.843 4 1.2 80 0.19 104 0.15 0.886 1.07 0.58–1.95
COR113 33480825 0.644 1 284 79 0.52 103 0.50 0.673 1.10 0.71–1.70
UM011 33510120 0.116 2 186 79 0.46 101 0.35 0.039 1.58 1.01–2.48
COR114 33516304 0.322 3 261 80 0.46 103 0.39 0.201 1.33 0.86–2.06
df degrees of freedom, Ad allele most associated with disease, p( A d) frequency of Ad, OR odds ratios
aOne-tailed































































































































































































































1  0.440  0.661  C  C  T  T  A  H  F  S  Q  L  H  L  L  R  P  D  A  E  E  V  G  Q 
1.2  0.082  0.115  .  T  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 
2  0.016  0.000  .  .  .  .  .  R  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 
3  0.206  0.000  T  A  .  C  T  .  .  .  .  .  .  .  .  .  R  S  .  .  .  .  .  P 
3.1  0.003  0.000  T  A  .  C  .  .  .  .  .  .  .  .  .  .  R  S  .  .  .  .  .  P 
3.2  0.003  0.083  T  A  A  C  .  .  .  .  .  .  .  .  .  .  R  S  .  .  .  .  .  P 
4  0.187  0.083  .  A  .  .  .  .  S  F  E  R  D  Y  V  .  R  S  .  .  K  Y  A  . 
5  0.063  0.057  .  A  .  .  .  .  S  F  E  R  D  Y  V  K  Y  .  . 
The sequence for allele 1 is shown as reference. Nucleotides and amino acids that are identical to the reference are depicted with a dot. Black
boxes indicate an indel. The grey area indicates variation located within the coding sequence
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in affected Icelandic horses compared to controls and was
significantly associated with IBH status (praw=0.004, OR=
3.60). Interestingly, we also found that allele 1 was possibly
protective (praw=0.015) in Icelandic horses (data not
shown). It was present at a frequency of 0.51 in healthy
horses but only 0.37 in affected horses, giving an odds ratio
of 0.58 (95% CI=0.38–0.91). Hence, the associations that
these alleles display are probably not due to their
phenotypic effect but rather due to LD with causal variants.
In the DRA gene, we detected three SNPs, all positioned
in the coding region. Two of these were non-synonymous
(Online resource 3). The SNPs define three alleles, which
correspond to three different polypeptide chains (Online
resource 7). At the protein level, the alleles were identical
to ELA-Eqca-DRA*0201 (Albright et al. 1991), ELA-
Eqca-DRA*0301 (Albright-Fraser et al. 1996) and ELA-
DRA*Hld105 (accession ACN66628). Only two of these
were found in the Exmoor Pony. We saw no association
between IBH status and DRA alleles in Icelandic horses or
Exmoor ponies.
The degree of LD between microsatellites, DRB3 and
DRA alleles was estimated for Icelandic horses and Exmoor
ponies separately (Online resources 5). The average degree
of LD was 0.37 in the Icelandic horses and 0.49 in the
Exmoor ponies. In an effort to find extended haplotypes
associated with disease, fastPHASE was used to phase both
microsatellite and exon 2 sequences. Unfortunately, too few
common haplotypes left the experiment underpowered and
so the potential of homozygosity mapping was explored.
Homozygosity
We combined microsatellite and sequencing data in order to
investigate the pattern of homozygosity throughout the
MHC class II region. In Icelandic horses, 0.13 of affected
individuals were homozygous, compared to only 0.04 of
the control horses. Homozygous horses were even more
prevalent in the Exmoor Pony population, with frequencies
of 0.30 and 0.15, respectively. A Cochran–Mantel–Haenszel
test, which combines data from both breeds, showed that
homozygosity in the region confers a higher risk of
developing a disease, with an odds ratio of 2.67 (p=0.0013,
95% CI=1.22–4.66).
Discussion
In this study, we showed that genetic variants in the MHC
class II gene clusters are associated with IBH susceptibility.
We tested over 350 horses and found the same allele (274
from COR112) associated with disease in two separate
populations. To our knowledge, this is the first time in any
atopic dermatitis-suffering species, including man, where
the same risk allele has been identified in two distinct
populations.
This is also the first equine study where direct DNA
genotyping, as an alternative to serology, has been used in
an association study to IBH. In a previous investigation of
the horse MHC class II region, Tseng et al. (2010) showed
that multiple microsatellite haplotypes could be associated
with a single serotype. DNA genotyping therefore provides
better resolution than earlier methodologies. In this partic-
ular study, phasing all markers (microsatellites, DRB3 and
DRA alleles) dramatically decreased the power to detect
associations. We used the extent of LD in our two
populations to examine why we did not observe common
long haplotypes associated with allele 274 from COR112.
For example, in the Icelandic horses, the marker DRB3 is in
highest LD with COR112, with LD estimated at 0.37 at a
genomic distance of 82 kb. This LD estimate is similar to
estimates in Icelandic horses published previously where
LD values, as measured in r
2, between SNPs were found to
be just below 0.20 for markers positioned approximately
100 kb apart (Wade et al. 2009). This low level of LD
indicates that recombination has broken the risk haplotype
between these markers. Further genotyping of densely
spaced markers, or direct sequencing, in a larger horse
material will be required to build informative haplotypes.
Candidate gene studies may suffer from undetected
stratification which increases the risk of false-positive
associations (Cardon and Palmer 2003). However, much
effort was taken to avoid stratification in the Icelandic
horses used. First, we inspected the pedigree of each horse
carefully and selected matched paternal half-siblings that
were unrelated (or distantly related) on the maternal side.
Second, all horses were genotyped using the Illumina
EquineSNP50 BeadChip. This provided an excellent
opportunity to test for stratification because genomewide
data provide a more reliable estimate of stratification
compared to a small number of neutral markers. The
genomes of these horses have thus been well characterized
and the relationship between cases and controls carefully
analysed. Because of the vast amount of genotypic data
available on the horses in this study, there is a low risk of
false-positives due to population substructure.
We demonstrated that being homozygous across the
MHC class II region influenced IBH susceptibility in both
the Icelandic Horse and in the Exmoor Pony population.
The level of homozygosity differs greatly between these
two horse breeds, with the latter having more homozygous
individuals. This is not surprising as the Icelandic Horse is
an old breed with over 200,000 registered horses world-
wide. Even though the Exmoor Pony is also a very old
breed, there have always been fewer representatives (fewer
than 3,000 registered ponies today) and these have mainly
206 Immunogenetics (2012) 64:201–208been localized in the southwest of England. In addition, the
Exmoor Pony endured a severe genetic bottleneck at the
time of the Second World War, when the population fell to
only 53 animals. A recent analysis of the studbook revealed
that only 24 mares and three stallions contributed signifi-
cantly to the present-day population, which constitutes
around 500 breeding animals (Baker 2008). The different
population structures and histories were also evident in the
average numbers of alleles (7.75 and 9.50 for Exmoor
ponies and Icelandic horses, respectively) as well as the
average degree of LD (0.49 and 0.37, respectively).
IBH is a complex disease that is likely controlled by a
combination of multiple genes and many environmental
factors. In a threshold sire model, we have previously
estimated the heritability for IBH in Icelandic horses born
in Sweden at 0.33 (s.d.<0.19) on an underlying, continuous
scale (Eriksson et al. 2008). Similar estimates have been
reported for Shetland ponies and Friesian horses with
heritability values at 0.24 (SE=0.06) and 0.29, respectively,
on the underlying scale (Ruyter 2005; Schurink et al. 2009).
Interestingly, a study performed on 330 Icelandic horses
exported from Iceland to Germany, Denmark and Sweden
found no heritability for the disease (Bjornsdottir et al.
2006). This may have been due to the focus on exported
horses. As discussed previously, horses exported from
Iceland have a higher prevalence of IBH compared to
horses born outside of Iceland. These two categories of
horses (born in versus outside of Iceland) are of similar
genetic background, but the greater environmental pres-
sures on exported horses likely cause the difference in IBH
prevalence. Increased environmental influences act to dilute
the impact of genetic variation and consequently the power
to dissect the genetic predisposition. In order to keep the
environmental variation to a minimum, our study focused
on Icelandic horses born in Sweden. Our hypothesis is that
among horses that develop IBH, those born in Sweden have
on average a stronger genetic predisposition, compared to
their counterparts imported from Iceland.
It is still unclear what the exact MHC class II causal
variants are. The different DRB3 isoforms have a direct
physiological role in B-cell antigen presentation to T-helper
cells. This process ultimately leads to the proliferation of
new B cells and production of antibodies. Because risk
allele 1.2 produces the same polypeptide as the protective
allele 1, there are most likely other variations that are
causative in this region. Deep sequencing of the entire
MHC class II region in targeted horses would be a logical
approach towards the identification of candidate genes and
ultimately causative quantitative trait nucleotides.
In conclusion, we have shown that variants in the MHC
class II region are associated with IBH susceptibility, with
the same allele associated in two separate populations. In
addition, we have also shown that homozygosity across the
entire MHC class II region is associated with a higher risk
of developing IBH.
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